Blood banking, also known as immunohematology, is a branch of laboratory medicine that deals with the preparation of blood and blood components for transfusion, as well as the selection and monitoring of those components after transfusion. Antigen-antibody responses and comparable phenomena as they relate to the pathophysiology and clinical symptoms of blood disorders are studied in immunohematology, a field of haematology and transfusion medicine. An immunohematologist is a professional who works in this discipline. Blood typing, cross-matching, and antibody identification are among their daily responsibilities. The antigen will be detected on the patient's red cells using the same techniques. A wide range of immuno-haematological procedures are utilised to discover and address diagnostic difficulties in patients with haematological disorders such as auto immune haemolytic anaemia. In immunohaematology, molecular approaches are increasingly being employed to establish a patient's antigen profile, solve complex challenges, and perform large-scale red cell type.
Title : Diagnosis and differentiation of lyme disease and tick-borne relapsing fever borreliosis with multiplex line immunoblots
Ranjan Ramasamy, IDFISH Technology, United States
Title : Mast cell degranulation links anti-PEG IgE to anaphylaxis caused by PEGylated drugs and PEG-contained LNP/mRNA COVID vaccines
Zhaohua Zhou, Food and Drug Administration, United States
Title : Genetic factors influencing early immunity to SARS-CoV-2 in the upper respiratory tract
Ranjan Ramasamy, IDFISH Technology, United States
Title : Monoclonal antibodies efficacy in treatment of novel coronavirus infection (COVID-19) in children at risk of developing a severe course of the disease
Ismail Osmanov, Children's city clinical hospital, Russian Federation
Title : Considerations on MS animal modeling: Format of myelin immunogens used for experimental autoimmune encephalomyelitis model establishment may affect pharmacologic responses of anti-inflammatory drugs
WenQing Yang, Founder/Chief Scientific Officer, ClinBridge Biotech Corp., China
Title : Regulatory T cells with chimeric antigen receptors as treatment for autoimmunity
Matthias Hardtke Wolenski, Hannover Medical School, Germany